Thermo Fisher Scientific Revenue 2010-2024 | TMO
Thermo Fisher Scientific annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Thermo Fisher Scientific revenue for the quarter ending September 30, 2024 was $10.598B, a 0.23% increase year-over-year.
- Thermo Fisher Scientific revenue for the twelve months ending September 30, 2024 was $42.370B, a 2.42% decline year-over-year.
- Thermo Fisher Scientific annual revenue for 2023 was $42.857B, a 4.58% decline from 2022.
- Thermo Fisher Scientific annual revenue for 2022 was $44.915B, a 14.55% increase from 2021.
- Thermo Fisher Scientific annual revenue for 2021 was $39.211B, a 21.71% increase from 2020.
| Thermo Fisher Scientific Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $42,857 |
| 2022 | $44,915 |
| 2021 | $39,211 |
| 2020 | $32,218 |
| 2019 | $25,542 |
| 2018 | $24,358 |
| 2017 | $20,918 |
| 2016 | $18,274 |
| 2015 | $16,965 |
| 2014 | $16,890 |
| 2013 | $13,090 |
| 2012 | $12,510 |
| 2011 | $11,559 |
| 2010 | $10,393 |
| 2009 | $9,912 |
| Thermo Fisher Scientific Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $10,598 |
| 2024-06-30 | $10,541 |
| 2024-03-31 | $10,345 |
| 2023-12-31 | $10,886 |
| 2023-09-30 | $10,574 |
| 2023-06-30 | $10,687 |
| 2023-03-31 | $10,710 |
| 2022-12-31 | $11,450 |
| 2022-09-30 | $10,677 |
| 2022-06-30 | $10,970 |
| 2022-03-31 | $11,818 |
| 2021-12-31 | $10,702 |
| 2021-09-30 | $9,330 |
| 2021-06-30 | $9,273 |
| 2021-03-31 | $9,906 |
| 2020-12-31 | $10,550 |
| 2020-09-30 | $8,521 |
| 2020-06-30 | $6,917 |
| 2020-03-31 | $6,230 |
| 2019-12-31 | $6,829 |
| 2019-09-30 | $6,272 |
| 2019-06-30 | $6,316 |
| 2019-03-31 | $6,125 |
| 2018-12-31 | $6,507 |
| 2018-09-30 | $5,920 |
| 2018-06-30 | $6,078 |
| 2018-03-31 | $5,853 |
| 2017-12-31 | $6,047 |
| 2017-09-30 | $5,116 |
| 2017-06-30 | $4,990 |
| 2017-03-31 | $4,765 |
| 2016-12-31 | $4,953 |
| 2016-09-30 | $4,491 |
| 2016-06-30 | $4,535 |
| 2016-03-31 | $4,295 |
| 2015-12-31 | $4,652 |
| 2015-09-30 | $4,123 |
| 2015-06-30 | $4,271 |
| 2015-03-31 | $3,919 |
| 2014-12-31 | $4,493 |
| 2014-09-30 | $4,171 |
| 2014-06-30 | $4,322 |
| 2014-03-31 | $3,904 |
| 2013-12-31 | $3,467 |
| 2013-09-30 | $3,192 |
| 2013-06-30 | $3,240 |
| 2013-03-31 | $3,192 |
| 2012-12-31 | $3,259 |
| 2012-09-30 | $3,086 |
| 2012-06-30 | $3,108 |
| 2012-03-31 | $3,057 |
| 2011-12-31 | $3,051 |
| 2011-09-30 | $2,933 |
| 2011-06-30 | $2,854 |
| 2011-03-31 | $2,721 |
| 2010-12-31 | $2,542 |
| 2010-09-30 | $2,629 |
| 2010-06-30 | $2,596 |
| 2010-03-31 | $2,627 |
| 2009-12-31 | $2,641 |
| 2009-09-30 | $2,531 |
| 2009-06-30 | $2,484 |
| 2009-03-31 | $2,255 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $196.322B | $42.857B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $195.140B | 102.02 |
| Alcon (ALC) | Switzerland | $42.414B | 28.38 |
| Edwards Lifesciences (EW) | United States | $41.569B | 26.40 |
| IQVIA Holdings (IQV) | United States | $36.630B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $34.166B | 40.24 |
| DexCom (DXCM) | United States | $28.447B | 42.84 |
| Waters (WAT) | United States | $22.175B | 32.79 |
| STERIS (STE) | Ireland | $21.157B | 24.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.795B | 0.00 |
| Hologic (HOLX) | United States | $18.343B | 19.36 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.004B | 13.35 |
| Sysmex ADR (SSMXY) | Japan | $12.946B | 40.60 |
| Globus Medical (GMED) | United States | $11.536B | 29.21 |
| Penumbra (PEN) | United States | $9.397B | 92.05 |
| Masimo (MASI) | United States | $9.260B | 44.81 |
| Teleflex (TFX) | United States | $8.904B | 14.20 |
| Glaukos (GKOS) | United States | $7.940B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.884B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.632B | 26.26 |
| Veracyte (VCYT) | United States | $3.068B | 92.07 |
| Inari Medical (NARI) | United States | $2.907B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.787B | 16.09 |
| TransMedics (TMDX) | United States | $2.552B | 80.89 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.024B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.820B | 9.51 |
| RxSight (RXST) | United States | $1.807B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.427B | 0.00 |
| Artivion (AORT) | United States | $1.185B | 78.53 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 14.53 |
| Paragon 28 (FNA) | United States | $0.841B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.723B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.638B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.593B | 13.97 |
| AxoGen (AXGN) | United States | $0.587B | 0.00 |
| SiBone (SIBN) | United States | $0.527B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.462B | 31.05 |
| Tactile Systems Technology (TCMD) | United States | $0.428B | 23.18 |
| CVRx (CVRX) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.312B | 0.00 |
| NeuroPace (NPCE) | United States | $0.290B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.278B | 0.00 |
| Inogen (INGN) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.194B | 0.00 |
| Nevro (NVRO) | United States | $0.169B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.60 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |